Skip to content
Home/Companies/Biotech/Biocrates
Biocrates

Biocrates

Biotech·Austria·Exited 2025·Held 6yr
Entry
2019
Hold
6yr
Exit
2025

Who owns Biocrates?

Biocrates is an Austrian Biotech company, now owned by Bruker, which acquired it in 2025 from MIG Capital.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
MIG Capital
Investor
MIG Capital
MIG Fonds 16 · 2019 · Evergreen

Key facts

HQAustria
SectorBiotech
StatusAcquired
Websitebiocrates.com
Exit Type
Trade Sale
Buyer
Bruker Corporation
Exit Year
2025

More from MIG Fonds 16

Other portfolio companies in the same fund.

mbiomics
mbiomics
Active
BiotechGermany· 2023
Inbolt
Inbolt
Active
Deep TechFrance· 2022
iOmx Therapeutics
iOmx Therapeutics
Active
BiotechGermany· 2021
Mimi Hearing Technologies
Mimi Hearing Technologies
Active
IndustrialsGermany· 2021
Zadient Technologies
Zadient Technologies
Active
Deep TechFrance· 2021
Innatera
Innatera
Active
Deep TechNetherlands· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Biocrates?

Biocrates is now owned by Bruker, which acquired it in 2025 from MIG Capital.

When did Bruker acquire Biocrates?

Bruker acquired Biocrates in 2025, buying from MIG Capital.

Who did Biocrates sell to?

MIG Capital sold Biocrates to Bruker in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue